These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

327 related items for PubMed ID: 11119125

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Genetic alterations in pediatric high-grade astrocytomas.
    Cheng Y, Ng HK, Zhang SF, Ding M, Pang JC, Zheng J, Poon WS.
    Hum Pathol; 1999 Nov; 30(11):1284-90. PubMed ID: 10571506
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Investigation of germline PTEN, p53, p16(INK4A)/p14(ARF), and CDK4 alterations in familial glioma.
    Tachibana I, Smith JS, Sato K, Hosek SM, Kimmel DW, Jenkins RB.
    Am J Med Genet; 2000 May 15; 92(2):136-41. PubMed ID: 10797439
    [Abstract] [Full Text] [Related]

  • 5. Genetic alterations commonly found in diffusely infiltrating cerebral gliomas are rare or absent in pleomorphic xanthoastrocytomas.
    Kaulich K, Blaschke B, Nümann A, von Deimling A, Wiestler OD, Weber RG, Reifenberger G.
    J Neuropathol Exp Neurol; 2002 Dec 15; 61(12):1092-9. PubMed ID: 12484572
    [Abstract] [Full Text] [Related]

  • 6. PTEN protein expression correlates with PTEN gene molecular changes but not with VEGF expression in astrocytomas.
    Idoate MA, Soria E, Lozano MD, Sola JJ, Panizo A, de Alava E, Manrique M, Pardo-Mindán FJ.
    Diagn Mol Pathol; 2003 Sep 15; 12(3):160-5. PubMed ID: 12960698
    [Abstract] [Full Text] [Related]

  • 7. p53 and PTEN gene mutations in gemistocytic astrocytomas.
    Watanabe K, Peraud A, Gratas C, Wakai S, Kleihues P, Ohgaki H.
    Acta Neuropathol; 1998 Jun 15; 95(6):559-64. PubMed ID: 9650746
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. p53 gene mutations in human astrocytic brain tumors including pilocytic astrocytomas.
    Patt S, Gries H, Giraldo M, Cervos-Navarro J, Martin H, Jänisch W, Brockmöller J.
    Hum Pathol; 1996 Jun 15; 27(6):586-9. PubMed ID: 8666369
    [Abstract] [Full Text] [Related]

  • 11. Deregulation of the TP53/p14ARF tumor suppressor pathway in low-grade diffuse astrocytomas and its influence on clinical course.
    Watanabe T, Katayama Y, Yoshino A, Komine C, Yokoyama T.
    Clin Cancer Res; 2003 Oct 15; 9(13):4884-90. PubMed ID: 14581362
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. PTEN, DMBT1, and p16 alterations in diffusely infiltrating astrocytomas.
    Fan X, Muñoz J, Sanko SG, Castresana JS.
    Int J Oncol; 2002 Sep 15; 21(3):667-74. PubMed ID: 12168116
    [Abstract] [Full Text] [Related]

  • 15. Loss of neurofibromatosis 1 (NF1) gene expression in NF1-associated pilocytic astrocytomas.
    Gutmann DH, Donahoe J, Brown T, James CD, Perry A.
    Neuropathol Appl Neurobiol; 2000 Aug 15; 26(4):361-7. PubMed ID: 10931370
    [Abstract] [Full Text] [Related]

  • 16. Correlation of histology and molecular genetic analysis of 1p, 19q, 10q, TP53, EGFR, CDK4, and CDKN2A in 91 astrocytic and oligodendroglial tumors.
    Ueki K, Nishikawa R, Nakazato Y, Hirose T, Hirato J, Funada N, Fujimaki T, Hojo S, Kubo O, Ide T, Usui M, Ochiai C, Ito S, Takahashi H, Mukasa A, Asai A, Kirino T.
    Clin Cancer Res; 2002 Jan 15; 8(1):196-201. PubMed ID: 11801559
    [Abstract] [Full Text] [Related]

  • 17. Genetic aberrations leading to MAPK pathway activation mediate oncogene-induced senescence in sporadic pilocytic astrocytomas.
    Jacob K, Quang-Khuong DA, Jones DT, Witt H, Lambert S, Albrecht S, Witt O, Vezina C, Shirinian M, Faury D, Garami M, Hauser P, Klekner A, Bognar L, Farmer JP, Montes JL, Atkinson J, Hawkins C, Korshunov A, Collins VP, Pfister SM, Tabori U, Jabado N.
    Clin Cancer Res; 2011 Jul 15; 17(14):4650-60. PubMed ID: 21610151
    [Abstract] [Full Text] [Related]

  • 18. Mutational analysis of the PTEN gene in gliomas: molecular and pathological correlations.
    Zhou XP, Li YJ, Hoang-Xuan K, Laurent-Puig P, Mokhtari K, Longy M, Sanson M, Delattre JY, Thomas G, Hamelin R.
    Int J Cancer; 1999 Apr 20; 84(2):150-4. PubMed ID: 10096247
    [Abstract] [Full Text] [Related]

  • 19. Abnormalities of p16, p15 and CDK4 genes in recurrent malignant astrocytomas.
    Saxena A, Robertson JT, Ali IU.
    Oncogene; 1996 Aug 01; 13(3):661-4. PubMed ID: 8760309
    [Abstract] [Full Text] [Related]

  • 20. MIB-1 and p53 immunocytochemistry for differentiating pilocytic astrocytomas and astrocytomas from anaplastic astrocytomas and glioblastomas in children and young adults.
    Matsumoto T, Fujii T, Yabe M, Oka K, Hoshi T, Sato K.
    Histopathology; 1998 Nov 01; 33(5):446-52. PubMed ID: 9839169
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.